CLINICAL ROLE -
Payers' Views on the Heterogeneity of Treatment Effect in Oncology
When making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.
Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin
Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
2 Clarke Drive Cranbury, NJ 08512